In the US, Halaven (eribulin systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic and Liposarcoma.
Ingredient matches for Halaven
Eribulin is reported as an ingredient of Halaven in the following countries:
- Hong Kong
Eribulin mesilate (a derivative of Eribulin) is reported as an ingredient of Halaven in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- South Korea
- United Kingdom
- United States
← International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.